Cargando…
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023585/ https://www.ncbi.nlm.nih.gov/pubmed/35277660 http://dx.doi.org/10.1038/s41416-022-01781-y |
_version_ | 1784690381957365760 |
---|---|
author | Rose, Tracy L. Weir, William H. Mayhew, Gregory M. Shibata, Yoichiro Eulitt, Patrick Uronis, Joshua M. Zhou, Mi Nielsen, Matthew Smith, Angela B. Woods, Michael Hayward, Michele C. Salazar, Ashley H. Milowsky, Matthew I. Wobker, Sara E. McGinty, Katrina Millburn, Michael V. Eisner, Joel R. Kim, William Y. |
author_facet | Rose, Tracy L. Weir, William H. Mayhew, Gregory M. Shibata, Yoichiro Eulitt, Patrick Uronis, Joshua M. Zhou, Mi Nielsen, Matthew Smith, Angela B. Woods, Michael Hayward, Michele C. Salazar, Ashley H. Milowsky, Matthew I. Wobker, Sara E. McGinty, Katrina Millburn, Michael V. Eisner, Joel R. Kim, William Y. |
author_sort | Rose, Tracy L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9023585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90235852022-04-28 Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience Rose, Tracy L. Weir, William H. Mayhew, Gregory M. Shibata, Yoichiro Eulitt, Patrick Uronis, Joshua M. Zhou, Mi Nielsen, Matthew Smith, Angela B. Woods, Michael Hayward, Michele C. Salazar, Ashley H. Milowsky, Matthew I. Wobker, Sara E. McGinty, Katrina Millburn, Michael V. Eisner, Joel R. Kim, William Y. Br J Cancer Correction Nature Publishing Group UK 2022-03-11 2022-05-03 /pmc/articles/PMC9023585/ /pubmed/35277660 http://dx.doi.org/10.1038/s41416-022-01781-y Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Correction Rose, Tracy L. Weir, William H. Mayhew, Gregory M. Shibata, Yoichiro Eulitt, Patrick Uronis, Joshua M. Zhou, Mi Nielsen, Matthew Smith, Angela B. Woods, Michael Hayward, Michele C. Salazar, Ashley H. Milowsky, Matthew I. Wobker, Sara E. McGinty, Katrina Millburn, Michael V. Eisner, Joel R. Kim, William Y. Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title | Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title_full | Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title_fullStr | Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title_full_unstemmed | Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title_short | Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
title_sort | correction to: fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023585/ https://www.ncbi.nlm.nih.gov/pubmed/35277660 http://dx.doi.org/10.1038/s41416-022-01781-y |
work_keys_str_mv | AT rosetracyl correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT weirwilliamh correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT mayhewgregorym correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT shibatayoichiro correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT eulittpatrick correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT uronisjoshuam correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT zhoumi correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT nielsenmatthew correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT smithangelab correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT woodsmichael correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT haywardmichelec correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT salazarashleyh correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT milowskymatthewi correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT wobkersarae correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT mcgintykatrina correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT millburnmichaelv correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT eisnerjoelr correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience AT kimwilliamy correctiontofibroblastgrowthfactorreceptor3alterationsandresponsetoimmunecheckpointinhibitioninmetastaticurothelialcancerarealworldexperience |